Improvement of renal graft function after conversion from a calcineurin inhibitor including immunosuppression to a mycophenolate sodium including regimen: A 4-year follow-up

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 142-147

  Heeg, M H J ^a   Mueller, G A ^a   Bramlage, C ^a   Homayounfar, K ^a   Muehlhausen, J ^a   Leha, A ^a   Koziolek, M J ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UREA NITROGEN BLOOD LEVEL;

ADULT; CALCINEURIN; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84873317266     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.10.028     Document Type: Article

References (21)

1. S. Hariharan, C.P. Johnson, B.A. Bresnahan Improved graft survival after renal transplantation in the United States, 1988-1996 N Engl J Med 342 2000 605
2. J.M. Morales, A. Andres, M. Rengel Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation Nephrol Dial Transplant 16 Suppl. 1 2001 121
3. B. Nankivell, R. Borrows, C. Fung The natural history of chronic allograft nephropathy N Engl J Med 349 24 2003 2326
4. J.R. Chapman Chronic calcineurin inhibitor nephrotoxicity - lest we forget Am J Transplant 11 2011 693
5. J.M. Grinyo, J.M. Cruzado Mycophenolate mofetil and sirolimus combination in renal transplantation Am J Transplant 6 2006 1991
6. S.M. Flechner, J. Kobashigawa, G. Klintmalm Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity Clin Transplant 22 1 2008 1
7. M.J. Casey, H.U. Meier-Kriesche Calcineurin inhibitors in kidney transplantation: friend or foe? Curr Opin Nephrol Hypertens 20 2011 610 615
8. R.Y. Calne, S. Thiru, P. McMaster Cyclosporin A in patients receiving renal allografts from cadaver donors Lancet 2 1978 1323
9. B.J. Nankivell, R.J. Borrows, C.L. Fung Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology Transplantation 78 2004 557 565
10. A. Sharif, S. Shabir, S. Chand, P. Cockwell, S. Ball, R. Borrows Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation J Am Soc Nephrol 22 11 2011 Nov 2107 2118
11. H.U. Meier-Kriesche, S. Li, R.W. Gruessner Immunosuppression: Evolution in practice and trends, 1994-2004 Am J Transplant 6 2006 1111
12. U. Heemann, D. Abramowicz, G. Spasovski European Renal Best Practice Work Group on Kidney Transplantation. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: A European Renal Best Practice (ERBP) position statement Nephrol Dial Transplant 26 2011 2099 2106
13. B. Sprangers, D.R. Kuypers, Y. Vanrenterghem Immunosuppression: does one regimen fit all? Transplantation 92 2011 251 261 15
14. M. Guba, J. Pratschke, C. Hugo SMART-Study Group Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation Transpl Int 25 2012 416 423
15. M.R. Weir, S. Mulgaonkar, L. Chan Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial Kidney Int 79 2011 897 907
16. H.U. Meier-Kriesche, P. Merville, H. Tedesco-Silva Mycophenolate mofetil initiation in renal transplant patients at different times posttransplantation: the TranCept Switch study Transplantation 91 2011 984 990 15
17. D.M. Lanese, J.D. Conger Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles J Clin Invest 91 1993 2144 2149
18. J.J. Curtis, R.G. Luke, E. Dubovsky Cyclosporin in therapeutic doses increases renal allograft vascular resistance Lancet 2 1986 477 479
19. W.W. Epinette, C.M. Parker, E.L. Jones Mycophenolic acid for psoriasis: a review of pharmacology, long-term efficacy, and safety J Am Acad Dermatol 17 1987 962 971
20. R. Marinari, R. Fleischmajer, A.H. Schragger Mycophenolic acid in the treatment of psoriasis: long term administration Arch Dermatol 113 1977 930 932
21. H.W. Sollinger, F.O. Belzer, M.H. Deierhoi RS-61443 (Mycophenolate mofetil): a multicenter study for refractory kidney transplant rejection Ann Surg 216 1992 513 519